How do insurance prior authorization requirements affect heart failure medication access?

Insurance prior authorization requirements can significantly delay or prevent patients from accessing life-saving heart failure medications, with prescription fill times taking two to six times longer.

What types of heart failure medications are most affected by prior authorization delays?

Newer heart failure drugs, specifically angiotensin receptor-neprilysin inhibitors (ARNIs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors, which have no generic alternatives, are significantly impacted by these delays.

Do prior authorization requirements contribute to health disparities in heart failure care?

Yes, prior authorization was found to be more common among poorer neighborhoods, Black and Hispanic individuals, and those on Medicaid, suggesting it may worsen health disparities in heart failure care.

Home / Health / Insurance Delays Cost Lives: Heart Meds Stalled

Insurance Delays Cost Lives: Heart Meds Stalled

17 Mar

•

Summary

Insurance prior authorization triples ARNI and quadruples SGLT2 inhibitor fill times.
Many patients abandon life-saving heart failure medications due to delays.
Prior authorization disproportionately affects poorer, minority, and Medicaid patients.

Insurance companies' prior authorization requirements may be hindering timely access to crucial heart failure medications, according to recent research. This process, where doctors must obtain insurer approval before a treatment is covered, can extend prescription fill times significantly.

Researchers found that for newer heart failure drugs with no generic alternatives, such as ARNIs and SGLT2 inhibitors, prior authorization led to fill times three to six times longer than usual. This delay discourages many patients, with some never filling their prescriptions, thereby missing out on potentially life-saving treatments.

These insurance policies, intended to control costs, may inadvertently cause harm by preventing patients from receiving recommended medications promptly. The study also highlighted that prior authorization was more prevalent among individuals from lower-income neighborhoods, Black and Hispanic populations, and those on Medicaid, suggesting it may exacerbate existing health disparities in heart failure care.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.